The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis.
 
Megan Buechel
No Relationships to Disclose
 
Danielle Enserro
No Relationships to Disclose
 
Robert Allen Burger
Honoraria - Expertix
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Gradalis; Immunogen; InVitae; Janssen Research & Development; Merck; Morphotek; Regeneron; Tesaro; VBL Therapeutics
 
Mark F. Brady
Consulting or Advisory Role - Aeterna Zentaris; Cel-Sci; Endocyte
 
Katrina Wade
No Relationships to Disclose
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Pharmaceuticals; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Genetics; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Merck (Inst); Morphotek (Inst); PharmaMar (Inst); Prima BioMed (Inst); Tesaro (Inst)
 
Andrew B. Nixon
Consulting or Advisory Role - Pfizer
Research Funding - Acceleron Pharma; Amgen; Genentech/Roche; Incyte; Leadiant Biosciences; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Seyedehnafiseh Mirniaharikandehei
No Relationships to Disclose
 
Hong Liu
No Relationships to Disclose
 
Bin Zheng
No Relationships to Disclose
 
Heidi Gray
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
David M. O'Malley
Honoraria - Clovis Oncology
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Janssen Oncology; Myriad Genetics; Novocure; Tesaro
Research Funding - Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Stem CentRx (Inst); Tesaro (Inst); TRACON Pharma (Inst); VentiRx (Inst)
 
Robert S. Mannel
Consulting or Advisory Role - Clovis Oncology (Inst); Tesaro (Inst)
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Oncology (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Research Funding - Lilly (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; Merrimack; Oxigene; Roche/Genentech; Sanofi; Threshold Pharmaceuticals